Brokerages Set Tenet Healthcare Corporation (NYSE:THC) Price Target at $247.67

Tenet Healthcare Corporation (NYSE:THC) has earned an average recommendation of “Moderate Buy” from the twenty-two analysts that are currently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has issued a strong buy rating on the company. The average 12-month target price among brokerages that have issued a report on the stock in the last year is $247.6667.

A number of research firms have recently weighed in on THC. Wells Fargo & Company restated an “overweight” rating and set a $265.00 target price on shares of Tenet Healthcare in a research report on Monday, February 16th. Cantor Fitzgerald upped their target price on shares of Tenet Healthcare from $190.00 to $245.00 and gave the company an “overweight” rating in a research report on Wednesday, October 29th. Guggenheim lifted their price target on shares of Tenet Healthcare from $257.00 to $271.00 and gave the stock a “buy” rating in a research report on Friday, February 13th. KeyCorp increased their price objective on shares of Tenet Healthcare from $225.00 to $250.00 and gave the company an “overweight” rating in a report on Thursday, February 12th. Finally, JPMorgan Chase & Co. upped their target price on shares of Tenet Healthcare from $200.00 to $230.00 and gave the company an “overweight” rating in a research report on Thursday, November 13th.

Tenet Healthcare Price Performance

Tenet Healthcare stock opened at $237.13 on Monday. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68. The business has a 50 day simple moving average of $204.26 and a 200 day simple moving average of $198.96. Tenet Healthcare has a one year low of $109.82 and a one year high of $240.83. The company has a market capitalization of $20.62 billion, a PE ratio of 15.31, a price-to-earnings-growth ratio of 1.16 and a beta of 1.44.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating the consensus estimate of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to the consensus estimate of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm’s revenue for the quarter was up 8.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, sell-side analysts forecast that Tenet Healthcare will post 12.24 EPS for the current fiscal year.

Insider Transactions at Tenet Healthcare

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of the firm’s stock in a transaction dated Monday, December 15th. The stock was sold at an average price of $197.47, for a total transaction of $430,089.66. Following the transaction, the director owned 28,480 shares in the company, valued at approximately $5,623,945.60. This trade represents a 7.10% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.81% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the company. Wedmont Private Capital raised its holdings in Tenet Healthcare by 2.5% in the fourth quarter. Wedmont Private Capital now owns 2,088 shares of the company’s stock worth $422,000 after purchasing an additional 50 shares during the period. Baron Wealth Management LLC lifted its holdings in Tenet Healthcare by 4.8% during the fourth quarter. Baron Wealth Management LLC now owns 1,142 shares of the company’s stock worth $227,000 after acquiring an additional 52 shares in the last quarter. Sagespring Wealth Partners LLC grew its stake in Tenet Healthcare by 3.6% in the fourth quarter. Sagespring Wealth Partners LLC now owns 1,573 shares of the company’s stock valued at $313,000 after acquiring an additional 55 shares during the period. Quadrant Capital Group LLC raised its position in shares of Tenet Healthcare by 0.7% during the fourth quarter. Quadrant Capital Group LLC now owns 8,134 shares of the company’s stock worth $1,616,000 after purchasing an additional 58 shares during the period. Finally, Syon Capital LLC grew its position in shares of Tenet Healthcare by 5.3% in the 4th quarter. Syon Capital LLC now owns 1,254 shares of the company’s stock valued at $249,000 after purchasing an additional 63 shares during the period. Institutional investors and hedge funds own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.